Caren Deardorf - Insider Trading & Ownership

Entity
Individual
Location
C/O Magenta Therapeutics, Inc., 100 Technology Square, Cambridge, Massachusetts
Summary
The estimated net worth of Caren Deardorf is at least $684 K dollars as of June 11, 2024. Caren Deardorf is the Director of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $446 K. Caren Deardorf is the Chief Commercial Officer of Magenta Therapeutics, Inc. and owns shares of Dianthus Therapeutics, Inc. /DE/ (DNTH) stock worth about $237 K.
All Insider Reports
All Insider Reports

Ownership of Caren Deardorf

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRNX Crinetics Pharmaceuticals, Inc. Director $446 K Jun 7, 2024
DNTH Dianthus Therapeutics, Inc. /DE/ Chief Commercial Officer $237 K Nov 30, 2022

Insider Transactions Reported by Caren Deardorf:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership